{"id":26645,"date":"2022-10-20T08:38:09","date_gmt":"2022-10-20T12:38:09","guid":{"rendered":"https:\/\/www.cosprc.ca\/?p=26645"},"modified":"2022-10-20T08:38:11","modified_gmt":"2022-10-20T12:38:11","slug":"canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis","status":"publish","type":"post","link":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/","title":{"rendered":"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis."},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

We are pleased to share with you the Canadian Rheumatology Association<\/strong> Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis.<\/strong>
 
These Canadian JIA-associated uveitis guidelines were developed by a working group of 14 pediatric rheumatologists, 6 ophthalmologists, 2 methodologists and 3 caregiver\/patient representatives using a GRADE-Adolopment approach applied to the 2019 ACR JIA-Associated Uveitis Guidelines. This streamlined method was chosen to develop Canadian guidelines considering the Canadian context, including patient preferences, cost\/resource considerations, and feasibility of implementation.

The recommendation has been published as a living guideline on MAGIC authoring and publication platform (MAGICapp) <\/strong>and has also been published as a full manuscript in the Journal of Rheumatology.<\/p>\n\n\n\n

Click here to read the CRA Recommendations for JIA-Associated Uveitis on MAGICapp<\/strong><\/a><\/p>\n\n\n\n

Click here to read the full manuscript published in the Journal of Rheumatology<\/strong><\/a><\/p>\n\n\n\n

Congratulations and thank you to the CRA Uveitis Guidelines Panel, led by Drs. Roberta Berard and Deb Levy, and supported by Guidelines Committee Chair Dr. Glen Hazlewood and methodologist Jordi Pardo Pardo. These guidelines were developed in collaboration with several ophthalmology colleagues and have been endorsed by the Canadian Ophthalmological Society Board. Special thanks as well to Dr. Arnav Agarwal for his assistance with the MAGICapp platform.<\/p>\n\n\n\n

The CRA will be sharing these documents with the larger rheumatology community including disease organizations, patient groups and Canadian media outlets. We encourage you to share it with your associates and colleagues via email or social media.

All media enquiries should be forwarded directly to Ahmad Zbib at azbib@rheum.ca<\/a> or through the CRA’s website at https:\/\/rheum.ca\/contact-us\/<\/a>.
 
On behalf of the CRA Board of Directors,

Ahmad M Zbib MD CPHIMS-CA
Chief Executive Officer
Canadian Rheumatology Association
Phone: 905-952-0698 EXT 8
Email: azbib@rheum.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

We are pleased to share with you the Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis. These Canadian JIA-associated uveitis guidelines were developed by a working group of 14 pediatric rheumatologists, 6 ophthalmologists, 2 methodologists and 3 caregiver\/patient representatives using a GRADE-Adolopment approach applied to the 2019 ACR JIA-Associated […]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[305,306,318],"post_tag":[],"content_type":[345],"class_list":["post-26645","post","type-post","status-publish","format-standard","hentry","category-pour-les-ophtalmologistes","category-pour-les-residents-et-les-boursiers","category-uveite","content_type-articles-fr"],"acf":[],"yoast_head":"\nCanadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis. - Practice Resource Centre<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis. - Practice Resource Centre\" \/>\n<meta property=\"og:description\" content=\"We are pleased to share with you the Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis. These Canadian JIA-associated uveitis guidelines were developed by a working group of 14 pediatric rheumatologists, 6 ophthalmologists, 2 methodologists and 3 caregiver\/patient representatives using a GRADE-Adolopment approach applied to the 2019 ACR JIA-Associated […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/\" \/>\n<meta property=\"og:site_name\" content=\"Practice Resource Centre\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-20T12:38:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-20T12:38:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cosprc.ca\/wp-content\/uploads\/2022\/10\/CRS-SCR.jpg\" \/>\n<meta name=\"author\" content=\"Admin Assistant\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin Assistant\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/\"},\"author\":{\"name\":\"Admin Assistant\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#\\\/schema\\\/person\\\/9ab88c133cdbf69968d498a38588ee75\"},\"headline\":\"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis.\",\"datePublished\":\"2022-10-20T12:38:09+00:00\",\"dateModified\":\"2022-10-20T12:38:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/\"},\"wordCount\":303,\"image\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cosprc.ca\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/CRS-SCR.jpg\",\"articleSection\":[\"Pour les ophtalmologistes\",\"Pour les r\u00e9sidents et les boursiers\",\"Uv\u00e9ite\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/\",\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/\",\"name\":\"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis. - Practice Resource Centre\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cosprc.ca\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/CRS-SCR.jpg\",\"datePublished\":\"2022-10-20T12:38:09+00:00\",\"dateModified\":\"2022-10-20T12:38:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#\\\/schema\\\/person\\\/9ab88c133cdbf69968d498a38588ee75\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/CRS-SCR.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cosprc.ca\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/CRS-SCR.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/\",\"name\":\"Practice Resource Centre\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cosprc.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#\\\/schema\\\/person\\\/9ab88c133cdbf69968d498a38588ee75\",\"name\":\"Admin Assistant\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1bb7ba3166135b524438491f96bc4d09514b58d4153f0c5fa19182fb727d6850?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1bb7ba3166135b524438491f96bc4d09514b58d4153f0c5fa19182fb727d6850?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1bb7ba3166135b524438491f96bc4d09514b58d4153f0c5fa19182fb727d6850?s=96&d=mm&r=g\",\"caption\":\"Admin Assistant\"},\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/author\\\/h4gznwtqqyl8bwjg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis. - Practice Resource Centre","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/","og_locale":"fr_FR","og_type":"article","og_title":"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis. - Practice Resource Centre","og_description":"We are pleased to share with you the Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis. These Canadian JIA-associated uveitis guidelines were developed by a working group of 14 pediatric rheumatologists, 6 ophthalmologists, 2 methodologists and 3 caregiver\/patient representatives using a GRADE-Adolopment approach applied to the 2019 ACR JIA-Associated […]","og_url":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/","og_site_name":"Practice Resource Centre","article_published_time":"2022-10-20T12:38:09+00:00","article_modified_time":"2022-10-20T12:38:11+00:00","og_image":[{"url":"https:\/\/www.cosprc.ca\/wp-content\/uploads\/2022\/10\/CRS-SCR.jpg","type":"","width":"","height":""}],"author":"Admin Assistant","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Admin Assistant","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/#article","isPartOf":{"@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/"},"author":{"name":"Admin Assistant","@id":"https:\/\/www.cosprc.ca\/#\/schema\/person\/9ab88c133cdbf69968d498a38588ee75"},"headline":"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis.","datePublished":"2022-10-20T12:38:09+00:00","dateModified":"2022-10-20T12:38:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/"},"wordCount":303,"image":{"@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cosprc.ca\/wp-content\/uploads\/2022\/10\/CRS-SCR.jpg","articleSection":["Pour les ophtalmologistes","Pour les r\u00e9sidents et les boursiers","Uv\u00e9ite"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/","url":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/","name":"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis. - Practice Resource Centre","isPartOf":{"@id":"https:\/\/www.cosprc.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/#primaryimage"},"image":{"@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cosprc.ca\/wp-content\/uploads\/2022\/10\/CRS-SCR.jpg","datePublished":"2022-10-20T12:38:09+00:00","dateModified":"2022-10-20T12:38:11+00:00","author":{"@id":"https:\/\/www.cosprc.ca\/#\/schema\/person\/9ab88c133cdbf69968d498a38588ee75"},"breadcrumb":{"@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/#primaryimage","url":"https:\/\/www.cosprc.ca\/wp-content\/uploads\/2022\/10\/CRS-SCR.jpg","contentUrl":"https:\/\/www.cosprc.ca\/wp-content\/uploads\/2022\/10\/CRS-SCR.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cosprc.ca\/fr\/canadian-rheumatology-association-recommendations-for-the-screening-monitoring-and-treatment-of-juvenile-idiopathic-arthritis-associated-uveitis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cosprc.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis\u2013Associated Uveitis."}]},{"@type":"WebSite","@id":"https:\/\/www.cosprc.ca\/#website","url":"https:\/\/www.cosprc.ca\/","name":"Practice Resource Centre","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cosprc.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.cosprc.ca\/#\/schema\/person\/9ab88c133cdbf69968d498a38588ee75","name":"Admin Assistant","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/1bb7ba3166135b524438491f96bc4d09514b58d4153f0c5fa19182fb727d6850?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1bb7ba3166135b524438491f96bc4d09514b58d4153f0c5fa19182fb727d6850?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1bb7ba3166135b524438491f96bc4d09514b58d4153f0c5fa19182fb727d6850?s=96&d=mm&r=g","caption":"Admin Assistant"},"url":"https:\/\/www.cosprc.ca\/fr\/author\/h4gznwtqqyl8bwjg\/"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-16 14:05:25","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts\/26645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/comments?post=26645"}],"version-history":[{"count":2,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts\/26645\/revisions"}],"predecessor-version":[{"id":26649,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts\/26645\/revisions\/26649"}],"wp:attachment":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/media?parent=26645"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/categories?post=26645"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/post_tag?post=26645"},{"taxonomy":"content_type","embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/content_type?post=26645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}